CYCLOPLEGIA IN CHILDREN

Trung Hầu Dương, Hằng Trần Thị Thu, Qúy Phạm Ngọc, Khoa Phạm Minh

Main Article Content

Abstract

Purpose: To determine factors related to select the ideal cycloplegic agents in prescribing glasses for children. Methods: A comprehensive literature review was conducted using PubMed, ScienceDirect, Elsevier, and Google Scholar databases using keywords such as “cyclopentolate”; “tropicamide”; “pediatric”; “cycloplegia”; “atropine”; and “cycloplegic” from inception to 2024. Results:  Atropine has the strongest cycloplegic effect and is recommended for cases of large accommodative esotropia. Because of the undesired side effects and risks from atropine, cyclopentolate has been found to offer a very effective cycloplegia even for moderate to high hyperopia and has become the standard of care for traditional pediatric cycloplegic exams. Tropicamide has also been shown to offer adequate cycloplegia with less toxicity and side effects. Conclusions: Accommodative power in children is at its maximum, and this interferes with reliable assessment of refraction. Therefore, the use of cycloplegic refraction is mandatory during childhood to obtain actual refraction, which is considered the cornerstone for eyeglass prescription. Selection the ideal cycloplegic agents depends on many factors especially including cycloplegic and side effects, needs to be individualized in each specific case.

Article Details

References

1. Patel T. Diagnostic drugs: part 2 – cycloplegics. . Optician. 2015:250.
2. Association AO. Evidence-Based Clinical Practice Guideline: Comprehensive Pediatric Eye and Vision Examination. OCP. Published online 2017:2-67.
3. Wallace DK, Morse CL, Melia M, et al. Pediatric Eye Evaluations Preferred Practice Pattern®: I. Vision Screening in the Primary Care and Community Setting; II. Comprehensive Ophthalmic Examination. Ophthalmology. 2018; 125(1):P184-P227.
4. Sowka JW, Kabat AG. Open your eyes to cycloplegia. Rev Optom. 2007:144.
5. Contreras-Salinas H, Orozco-Ceja V, Romero-López MS, Barajas-Virgen MY, Baiza-Durán LM, Rodríguez-Herrera LY. Ocular Cyclopentolate: A Mini Review Concerning Its Benefits and Risks. Clin Ophthalmol. 2022;16:3753-3762.
6. Rosenbaum AL, Bateman JB, Bremer DL, Liu PY. Cycloplegic refraction in esotropic children. Cyclopentolate versus atropine. Ophthalmology. 1981;88(10):1031-1034.
7. Liu X, Zhang F, Fan L. Evaluation of cycloplegic effectiveness of cyclopentolate and atropine. Chinese Journal of Experimental Ophthalmology. Published online 2012.
8. Farhood Q. Farhood Q. Cycloplegic refraction in children with cyclopentolate versus atropine. J Clin Exp Ophthalmol. 2012;3:1–6.
9. Al-Thawabieh W, Al-Omari R, Abu-Hassan DW, Abuawwad MT, Al-Awadhi A, Abu Serhan H. Tropicamide Versus Cyclopentolate for Cycloplegic Refraction in Pediatric Patients With Brown Irides: A Randomized Clinical Trial. Am J Ophthalmol. 2024;257:218-226.
10. Pei R, Liu Z, Rong H, et al. A randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in Chinese young adults with dark irises. BMC Ophthalmol. 2021;21(1):256.